Leah Johnson is an expert in the design and development of advanced materials for applications in energy and health. Her research focus includes engineered polymeric systems for controlled delivery, tissue engineering, biosensing, and diagnostics. By leading highly collaborative research efforts, she addresses gaps in translating early stage products through implementation and market adoption.
Dr. Johnson has served as lead investigator in projects for private industry and government agencies, spearheading product development for drug delivery and nanomaterial systems. Prior to joining RTI in 2012, she completed a postdoctoral fellowship at Duke University, held research positions at Gilead Sciences and Pfizer, and served as a patent analyst at Lathrop & Gage Law Offices.